causal

NordICC Trial Was Effectiveness Not Efficacy

The NordICC trial's discouraging all-cause mortality result for colonoscopy is undermined because it was an effectiveness trial (only 40% complied) recommending colonoscopy just once per 10 years, an interval Attia considers far too infrequent given cancers can appear one to two years after a normal colonoscopy.

causalpending

Speaker

Peter Attia

Evidence Quote

“this was an effectiveness trial of colonoscopy... 40% of them did... There's literature showing that people can develop colon cancer as little as one to two years after a completely normal colonoscopy... what I would say is 10 years is far too infrequent.”

Source

Peter Attia on Lifespan, Healthspan, and Outlive— EconTalk
Created: 6/13/2026, 12:18:42 AM

Your notes

Loading notes...